- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid ; volume:4 ; number:10 ; year:2012 ; pages:1032-1042 ; extent:11
EMBO molecular medicine / European Molecular Biology Organization ; 4, Heft 10 (2012), 1032-1042 (gesamt 11)
- Urheber
-
Hartkoorn, Ruben C.
Sala, Claudia
Neres, João
Pojer, Florence
Magnet, Sophie
Mukherjee, Raju
Uplekar, Swapna
Boy‐Röttger, Stefanie
Altmann, Karl‐Heinz
Cole, Stewart T.
- DOI
-
10.1002/emmm.201201689
- URN
-
urn:nbn:de:101:1-2023022406565210096815
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hartkoorn, Ruben C.
- Sala, Claudia
- Neres, João
- Pojer, Florence
- Magnet, Sophie
- Mukherjee, Raju
- Uplekar, Swapna
- Boy‐Röttger, Stefanie
- Altmann, Karl‐Heinz
- Cole, Stewart T.
Ähnliche Objekte (12)
Treatment of isoniazid-resistant pulmonary tuberculosis
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release
Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report
Eigenschaften Isoniazid-resistenter Mycobacterium tuberculosis Stämme unter besonderer Berücksichtigung des Sauerstoffverbrauches als Virulenzkriterium
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release
Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report
Eigenschaften Isoniazid-resistenter Mycobacterium tuberculosis Stämme unter besonderer Berücksichtigung des Sauerstoffverbrauches als Virulenzkriterium
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release
Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report
Eigenschaften Isoniazid-resistenter Mycobacterium tuberculosis Stämme unter besonderer Berücksichtigung des Sauerstoffverbrauches als Virulenzkriterium